SMTL ID : 6mq3.1 (1 other biounit)

Structure of Cysteine-free Human Insulin-Degrading Enzyme in complex with Substrate-selective Macrocycle Inhibitor 63

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.57 Å

Oligo State

homo-dimer

Ligands

2 x J22: {(8R,9S,10S)-9-(2',3'-dimethyl[1,1'-biphenyl]-4-yl)-6-[(1-methyl-1H-imidazol-2-yl)sulfonyl]-1,6-diazabicyclo[6.2.0]decan-10-yl}methanol(Non-covalent)

J22.1: 20 residues within 4Å: Chain A: A.157, L.160, F.161, L.163, E.164, T.167, Y.261, I.263, Y.273, T.275, V.319, G.320, G.321, Q.322, K.323, I.333, N.335, R.436, V.437, A.438 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.160, A:E.164, A:E.164, A:Y.273, A:Y.273, A:A.438 Hydrogen bonds: A:N.335 J22.3: 17 residues within 4Å: Chain B: A.157, L.160, F.161, L.163, E.164, T.167, Y.261, I.263, Y.273, T.275, V.319, Q.322, K.323, I.333, N.335, R.436, A.438 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:E.164, B:Y.261, B:Y.273, B:Y.273, B:Y.273, B:A.438

2 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.2: 11 residues within 4Å: Chain A: Q.759, E.768, R.798, A.799, N.800, G.801, R.852, E.869, S.872, Q.874, R.879 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Q.759, A:R.798, A:N.800, A:G.801 Salt bridges: A:E.869 EPE.4: 11 residues within 4Å: Chain B: Q.759, R.798, A.799, N.800, G.801, R.852, G.868, E.869, S.872, Q.874, R.879 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:Q.759, B:R.798, B:N.800, B:G.801, B:Q.874 Salt bridges: B:E.869

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Maianti, J.P. et al., Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme. Nat.Chem.Biol. (2019)

Release Date

2019-04-03

Peptides

Insulin-degrading enzyme: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Insulin-degrading enzyme

Related Entries With Identical Sequence